Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.

MLA

Mawad, Raya, et al. “Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.” Biology of Blood & Marrow Transplantation, vol. 20, no. 9, Sept. 2014, pp. 1363–68. EBSCOhost, https://doi.org/10.1016/j.bbmt.2014.05.014.

APA

Mawad, R., Gooley, T. A., Rajendran, J. G., Fisher, D. R., Gopal, A. K., Shields, A. T., Sandmaier, B. M., Sorror, M. L., Deeg, H. J., Storb, R., Green, D. J., Maloney, D. G., Appelbaum, F. R., Press, O. W., & Pagel, J. M. (2014). Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome. Biology of Blood & Marrow Transplantation, 20(9), 1363–1368. https://doi.org/10.1016/j.bbmt.2014.05.014

Chicago

Mawad, Raya, Ted A. Gooley, Joseph G. Rajendran, Darrell R. Fisher, Ajay K. Gopal, Andrew T. Shields, Brenda M. Sandmaier, et al. 2014. “Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.” Biology of Blood & Marrow Transplantation 20 (9): 1363–68. doi:10.1016/j.bbmt.2014.05.014.